Alerts & notifications
-
New benzodiazepine ethylbromazolam detected in New ZealandNotification|13 March 2025
A new benzodiazepine has been detected in New Zealand in a variety of forms, including tablets pressed to resemble legitimate pharmaceutical benzodiazepines.
-
New synthetic cannabinoid misrepresented as a benzodiazepineNotification|14 February 2025
A new synthetic cannabinoid AB-MDMSBA has been detected in a white powder presumed to be a benzodiazepine.
-
Synthetic Cannabinoid misrepresented as DMTNotification|03 May 2024
UPDATED 3 May 2024
Synthetic Cannabinoid MDMB-4en-PINACA has been detected in a yellow powder presumed to be DMT -
Potential adulteration of GBL in AucklandNotification|14 April 2022
We've identified harm linked to the potential adulteration of GBL and GBL-type substances in Auckland.
-
Toxic chemical sold as 1,4-BD in AucklandNotification|24 December 2021
The toxic chemical diethylene glycol being sold as the recreational drug 1,4-Butanediol (1,4-BD) in Auckland.
-
Synthetic cannabinoid harm in TaranakiNotification|05 July 2021
A particularly dangerous batch of synthetic cannabinoids is currently present in Taranaki.
-
Toxic chemical sold as MDMA in AucklandNotification|06 November 2020
The toxic chemical methylenedianiline is being sold as MDMA in Auckland.
-
Flualprazolam found in fake ‘Xanax’ tabletNotification|12 October 2020
Flualprazolam, a dangerous and potent novel benzodiazepine, has been detected in yellow counterfeit Xanax pills being sold across New Zealand.
-
Serious incidents linked to synthetic cannabinoids in TaranakiNotification|02 October 2020
A number of harm incidents involving synthetic cannabinoids have occurred in the Taranaki region.
-
AMB-FUBINACA detectedNotification|22 September 2020
The synthetic cannabinoid AMB-FUBINACA has been detected in a number of locations across New Zealand.